TruNiagen

Is the US a slow motion Longevity disaster?

Latest articles

SuperAger brains work all the tangles

New research demonstrates that SuperAger brains can resist the protein tangles that lead to Alzheimer's. Northwestern Medicine scientists have showed that SuperAgers' brains have resistance...

The Sheekey Science Show: NAD+ rejuvenation strategies

NAD+ metabolism in aging & three strategies to rejuvenate. Welcome to The Sheekey Science Show! Longevity.Technology is delighted to partner with YouTube sensation Eleanor Sheekey (interviewed...

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

BioAge kicks off Phase 2 longevity clinical trial

Company reveals primary indicator for BGE-117 clinical trial is unexplained anaemia of aging. Hot on the heels of its monster $90 million Series C funding...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Apollo Neuro

Editor's picks

SuperAger brains work all the tangles

New research demonstrates that SuperAger brains can resist the protein tangles that lead to Alzheimer's. Northwestern Medicine scientists have showed that SuperAgers' brains have resistance...

The Sheekey Science Show: NAD+ rejuvenation strategies

NAD+ metabolism in aging & three strategies to rejuvenate. Welcome to The Sheekey Science Show! Longevity.Technology is delighted to partner with YouTube sensation Eleanor Sheekey (interviewed...

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...
ChromaDex Tru Niagen

New report finds that sick care in the USA will become increasingly expensive and ineffective as the population ages – the US government needs to act quickly.

A new case study published by the Aging Analytics Agency and Targeting Metabesity 2019 identifies key Longevity deficits linked to health and wealth shortfalls in the United States. The study, released to coincide with the beginning of this week’s Targeting Metabesity 2019 conference, examines the links between metabesity, Longevity and the USA’s current health shortfalls, including low health-adjusted life expectancy (HALE).

A new case study published by the Aging Analytics Agency and Targeting Metabesity 2019 identifies key Longevity deficits linked to health and wealth shortfalls in the United States.
‘Metabesity’ is a term used to encompass the constellation of interconnected diseases with metabolic roots.

Starting today in Washington, DC, Targeting Metabesity 2019 is focused on the prevention of noncommunicable diseases and the treatment of age-related health dysfunctions to extend health-adjusted life expectancy. The conference will address the constellation of major chronic diseases, including diabetes, cardiovascular disease, dementia, cancer, and the aging process – widely considered to be a “slow motion disaster.”

The report also looks at the large gap between HALE and life expectancy in the USA (despite the country’s high per-capita healthcare expenditures) and provides policy recommendations to address the health vs wealth deficit.

“Therapies for extending health-span are on the near-term horizon and are well within reach provided there is a receptive regulatory environment to manage them,”  said Dr Michael Zemel, CSO, NuSirt Biopharma. “Longevity extension, on the other hand, may seem difficult to impossible, but in reality this ‘impossibility’ will just take a little longer in a supportive environment for clinical development.”

The USA holds the greatest share of the multi-trillion dollar global Longevity economy and the majority share of global Longevity industry companies and players. It also has one of the highest rates of healthcare expenditure.

According to the report, the USA has all the resources necessary to become a global leader in Longevity, preventive medicine and precision health, but lacks national prioritization by its federal government, and a strategy to unite the activities of its relevant industry ecosystems to work in synergy.

“The drugs and treatments that have resulted from America’s commitment to medical science have benefited – and saved – countless lives,” said Breanna Deutsch, former Press Secretary and Communications Director for the US Congress. “In order to continue leading the world in biomedical innovation, America’s policymakers and regulators must recognize the importance of longevity research and work to clear the federal roadblocks preventing this new era of medicine from reaching the public.”

The report suggests that finding synergies between Longevity research, P4 medicine and Artificial Intelligence has the potential to enable rapid and widespread policy and infrastructural reforms for US healthcare to quickly boost national Longevity, but only with sufficient government commitment.

“As was the case at the cusp of the moon shot or the human genome project, it seems increasingly a question of when, not if, emerging science will enable us to slow or even reverse human aging,” said Thomas Seoh, President and CEO, Kinexum. “What we need now is socioeconomic and policy alignment to accelerate the translation of this emerging science into material, accessible gains in public health. Preventing chronic diseases and extending healthspan constitute some of the most leveraged opportunities in healthcare in coming decades.”

Photo credit: Mark Waugh / Alamy Stock Photo
Danny Sullivan
Contributing Editor Danny has worked in technology communications for more than 15 years, spanning Europe and North America. From bionics and lasers to software and pharmaceuticals – and everything in between – he’s covered it all. Danny has wide experience of technology publishing and technical writing and has specific interest in the transfer from idea to market.
ChromaDex Tru Niagen

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...

It’s time to sit up and take notice of mitochondria

CohBar CEO on the development of a “true portfolio” of mitochondria based therapeutics. US biotech company CohBar is developing mitochondria-based therapeutics for the treatment of...
Apollo Neuro

Related articles

BioAge kicks off Phase 2 longevity clinical trial

Company reveals primary indicator for BGE-117 clinical trial is unexplained anaemia of aging. Hot on the heels of its monster $90 million Series C funding...

Gene-editing tool can programme cuts over time

New process uses special molecules called 'proGuides' to improve CRISPR gene editing. Researchers from the University of Illinois Chicago have discovered a new gene-editing technique...

A new link in longevity therapeutics

A key review sums up evidence linking DNA damage to senescence through cytoplasmic chromatin fragments, opening a new avenue for longevity therapeutics. Cellular senescence is...

Spermidine may halt aging by preserving telomere length

Researchers show that the natural autophagy-inducing compound spermidine may protect mice from age-related disorders by preventing telomere erosion. Aging is a natural process characterised by...

NIA announces funding for longevity clinical trials

New funding opportunity for longevity clinical trials from National Institute on Aging emphasises preventing aging and age-related disease. The NIA, which is part of the...
TruNigen pf